Results 101 to 110 of about 5,658 (197)

Flupirtine derivatives as potential treatment for the neuronal ceroid lipofuscinoses

open access: yesAnnals of Clinical and Translational Neurology, 2018
Objective Neuronal Ceroid Lipofuscinoses (NCL) are fatal inherited neurodegenerative diseases with established neuronal cell death and increased ceramide levels in brain, hence, a need for disease‐modifying drug candidates, with potential to enhance ...
Joelle Makoukji   +7 more
doaj   +1 more source

Lysosomal alterations and decreased electrophysiological activity in CLN3 disease patient-derived cortical neurons

open access: yes, 2022
CLN3 disease is a lysosomal storage disorder associated with fatal neurodegeneration that is caused by mutations in CLN3, with most affected individuals carrying at least one allele with a 966 bp deletion.
Richard Wilson (14753071)   +12 more
core  

Function of Kv4.2/KChIP3 channel complexes with coexpressed lysosomal protein CLN3 [PDF]

open access: yes, 2019
Kv4.2-Kanäle sind spannungsgesteuerte Kaliumkanäle, die sowohl schnell aktivieren als auch schnell inaktivieren. Sie vermitteln den A-Typ-Strom (ISA) und regulieren die dendritische Erregung im ZNS. An diesen Kanal kann sich KChIP3 als akzessorische beta-
Seifert, Anja Carolin
core  

Lack of specificity of antibodies raised against CLN3, the lysosomal/endosomal transmembrane protein mutated in juvenile Batten disease

open access: yes, 2017
Juvenile CLN3 (Batten) disease, a fatal, childhood neurodegenerative disorder, results from mutations in the CLN3 gene encoding a lysosomal/endosomal transmembrane protein.
David A. Pearce   +2 more
core   +1 more source

Targeted Disruption of the Cln3 Gene Provides a Mouse Model for Batten Disease

open access: yesNeurobiology of Disease, 1999
Batten disease, a degenerative neurological disorder with juvenile onset, is the most common form of the neuronal ceroid lipofuscinoses. Mutations in the CLN3 gene cause Batten disease.
Hannah M. Mitchison   +13 more
doaj   +1 more source

Ribosome profile of CLN3 mRNA.

open access: yes, 2013
Ribosome densities in the CLN3 region are shown for WT (upper) and whi3 (middle) cells. The x-axis shows the footprint position relative to the sense strand of CLN3.
Ying Cai (22305), Bruce Futcher (4349)
core   +1 more source

Novel CLN3 mutation causing autophagic vacuolar myopathy.

open access: yes, 2014
OBJECTIVE: To identify the genetic cause of a complex syndrome characterized by autophagic vacuolar myopathy (AVM), hypertrophic cardiomyopathy, pigmentary retinal degeneration, and epilepsy. METHODS: Clinical, pathologic, and genetic study.
Ricca I2   +20 more
core   +2 more sources

Increased osmolarity upregulates myc-CLN3 protein expression.

open access: yes, 2013
(A) Hyperosmolarity induced by NaCl/urea dramatically increases myc-CLN3 protein expression. BHK clone 19 myc-CLN3-expressing and BHK clone 2 UB6 empty vector-expressing cells were grown under isotonic (300 mOsm) or hyperosmotic conditions.
Amanda Getty (424612)   +6 more
core   +1 more source

Drafting the CLN3 Protein Interactome in SH-SY5Y Human Neuroblastoma Cells: A Label-free Quantitative Proteomics Approach

open access: yes, 2016
Neuronal ceroid lipofuscinoses (NCL) are the most common inherited progressive encephalopathies of childhood. One of the most prevalent forms of NCL, Juvenile neuronal ceroid lipofuscinosis (JNCL) or CLN3 disease (OMIM: 204200), is caused by mutations in
Jaana Tyynelä (1930768)   +10 more
core   +2 more sources

CLN3 deficient cells display defects in the ARF1-Cdc42 pathway and actin-dependent events.

open access: yesPLoS ONE, 2014
Juvenile Batten disease (juvenile neuronal ceroid lipofuscinosis, JNCL) is a devastating neurodegenerative disease caused by mutations in CLN3, a protein of undefined function.
Mark L Schultz   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy